About the Event
With the cost of technologies declining, why has the cost of health tech continued to rise? Can hospitals afford the latest innovations? This presentation will cover market needs and investment trends in health IT and explore whether or not the two are aligned.
Join us for the August installment of the Texas Health CoLab Learning Series to discover how the influx of capital has impacted the health care industry.
About the Speaker
Emma Cartmell is a proven health tech investor, following a 20-year career building, acquiring, selling and taking companies public. Cartmell served as the COO of NantHealth, a $1 billion private equity fund, where she built the team and led investments and acquisitions. Before that, Cartmell was the COO of personalized medicine at Abraxis BioScience, where she prepared the company for sale and helped negotiate an eight-times revenue sale to Celgene for $2.9 billion. Earlier in her career, she was vice president of health care advanced programs and director of business development at SAIC, where she held both P&L and revenue-generating responsibilities for a $500 million health care business. Cartmell has developed M&A strategies for public and private companies on both the buy- and sell-side, with investment targets of up to $1 billion. She also advises the Morgan Stanley Equity Research team on the digital health market. She personally invests in health care technology startups, both individually and as a member of the Central Texas Angel Network.